Valproic acid suppresses G1 phase‐dependent sialylation of a 65 kDa glycoprotein in the C6glioma cell cycle

Publisher Website
Google Scholar
Abstract
The influence of valproate on invitro glycosylation events in C6 glioma has been investigated, as this major human teratogen restricts proliferation in the mid‐G1 phase of the cycle and alters the prevalence and/or glycosylation state of cell surface glycoproteins with the potential to mediate cell–cell and cell–matrix interactions critical to development. C6 glioma cultured continuously in the presence of 1 mM valproate exhibited a significant depression of exponential growth but attained confluency one day later, when the majority of cells entered the G1 phase of the cycle. Glycoprotein sialyltransferase, which exhibited a four‐fold increase during exponential growth and a small decrease at confluency, was markedly attenuated in valproate‐exposed cells in a manner which was indirect. This was associated with an inhibition of transient α2,3 sialylation of a 65 kDa glycoprotein expressed maximally at 4 hr into the G1 phase of the cell cycle. This effect was cell‐cycle phase‐specific, as exposure of synchronized cells to valproate inhibited transient sialylation at 4 and 5 hr into the G1 phase. Inhibition of the 65 kDa glycoprotein sialylation by valproate is suggested to arise from impaired signal transduction preceding the eventual arrest by the drug at a 5–6 hr G1 phase restriction point.
Funding Information
  • EU Biotechnology Programme